You just read:

BioSpecifics Technologies Corp. Initiates Phase 1 Clinical Trial of XIAFLEX for Treatment of Uterine Fibroids

News provided by

BioSpecifics Technologies Corp.

Apr 18, 2017, 08:00 ET